Gautam Shah
Keine laufenden Positionen mehr
Karriereverlauf von Gautam Shah
Ehemalige bekannte Positionen von Gautam Shah
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ACHILLION PHARMACEUTICALS, INC. | Compliance Officer | 20.07.2012 | 25.03.2015 |
| General Counsel | 01.05.2004 | 31.03.2015 | |
| VISION CORPORATION LIMITED | Präsident | - | 13.05.2009 |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | General Counsel | 01.02.2003 | 01.05.2004 |
Ausbildung von Gautam Shah
| Wayne State University (Michigan) | Graduate Degree |
| University of Illinois | Doctorate Degree |
| University of Baroda | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
| Indien | 3 |
Operativ
| General Counsel | 2 |
| Compliance Officer | 1 |
| Doctorate Degree | 1 |
Sektoral
| Consumer Services | 5 |
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| VISION CORPORATION LIMITED | Consumer Services |
| Private Unternehmen | 2 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
Achillion Pharmaceuticals, Inc.
 Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Achillion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of oral small molecule complement system inhibitors. Its pipeline includes Danicopan and ACH-5228. The company was founded on August 17, 1998 and is headquartered in Blue Bell, PA. | Health Technology |
- Börse
- Insiders
- Gautam Shah
- Erfahrung
